MedTrace Logo

The Role of ICSI in Non-male Factor Infertility in Advanced Maternal Age

NCT03370068 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2020-07-28

No results posted yet for this study

Summary

The use of Intracytoplasmic sperm injection (ICSI) has increased in the last decades regardless of the cause of infertility. Despite the increased use there is no clear evidence that ICIS is more effective than conventional in vitro fertilization (IVF) for non-male factor infertility. The investigators therefore aim to perform a prospective randomized controlled study to compare between ICSI and conventional IVF in women between 39 to 44 years of age with non-male factor infertility.

Conditions

  • Infertility, Female

Interventions

OTHER

ICSI

Oocytes retrieved from one ovary will undergo insemination by ICSI.

OTHER

Conventional IVF

Oocytes retrieved from the second ovary will undergo insemination by conventional IVF

Sponsors & Collaborators

  • Dr. Tal Miller-Elkan

    lead OTHER_GOV

Principal Investigators

  • Tal TE Elkan Miller, MD PhD · Sheba Medical Cente

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
39 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-07-01
Completion
2020-07-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03370068 on ClinicalTrials.gov